Octagon Capital Advisors LP
CIK 1839435 · Holdings on Mar 31, 2024 · First reported May 15, 2024
Top ten holdings
Q1 2024- APLS20.06%
- NVLS5.98%
- DNTH5.04%
- VRNA4.63%
- DYN4.29%
- AVBP4.22%
- INSM3.76%
- CNTA2.83%
- EYPT2.75%
- OCUL2.68%
Share classes counted separately56.24%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- APLSWeight decreased · -6.82 pp26.88% → 20.06%Shares 0 (0.00%)
- DNTHWeight increased · +4.12 pp0.92% → 5.04%Shares +826.67K (+149.22%)
- VRNAWeight decreased · -2.91 pp7.54% → 4.63%Shares 0 (0.00%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 29
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | APLSAPELLIS PHARMACEUTICALS INC View history and evidence | $164.99M | 20.06% | 2.81M shares | 26.88% → 20.06%-6.82 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | NVLSALPINE IMMUNE SCIENCES INC View history and evidence | $49.21M | 5.98% | 1.24M shares | 3.79% → 5.98%+2.19 pp 0 (0.00%) | Unchanged | ↗▾ |
| 03 | DNTHDIANTHUS THERAPEUTICS INC View history and evidence | $41.42M | 5.04% | 1.38M shares | 0.92% → 5.04%+4.12 pp +826.67K (+149.22%) | Added | ↗▾ |
| 04 | VRNAVERONA PHARMA PLC - ADRSPONSORED ADS View history and evidence | $38.12M | 4.63% | 2.37M shares | 7.54% → 4.63%-2.91 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | DYNDYNE THERAPEUTICS INC View history and evidence | $35.29M | 4.29% | 1.24M shares | 1.69% → 4.29%+2.60 pp +450.00K (+56.75%) | Added | ↗▾ |
| 06 | AVBPARRIVENT BIOPHARMA INC View history and evidence | $34.72M | 4.22% | 1.94M shares | Prior unavailable +1.94M | New | ↗▾ |
| 07 | INSMINSMED INCCOM PAR $.01 View history and evidence | $30.93M | 3.76% | 1.14M shares | 6.37% → 3.76%-2.61 pp -144.00K (-11.21%) | Reduced | ↗▾ |
| 08 | CNTACENTESSA PHARMACEUTICALS-ADRSPONSORED ADS View history and evidence | $23.28M | 2.83% | 2.06M shares | 2.62% → 2.83%+0.21 pp 0 (0.00%) | Unchanged | ↗▾ |
| 09 | EYPTEYEPOINT INCCOM NEW View history and evidence | $22.60M | 2.75% | 1.09M shares | Prior unavailable +1.09M | New | ↗▾ |
| 10 | OCULOCULAR THERAPEUTIX INC View history and evidence | $22.07M | 2.68% | 2.42M shares | Prior unavailable +2.42M | New | ↗▾ |
Options overlay 1
$11.76M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
APLSAPELLIS PHARMACEUTICALS INC View history and evidence | Call | 200.00K | $11.76M | +200.00K | ▾ |
1 / 1 options · preview only
Exited positions 9
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| CBAY CYMABAY THERAPEUTICS INC | Non-derivative | -2,673,750 | -$63.15M | SEC filing ↗ | SEC filing ↗ |
| RCUS ARCUS BIOSCIENCES INC | Non-derivative | -1,868,000 | -$35.68M | SEC filing ↗ | SEC filing ↗ |
| CLDX CELLDEX THERAPEUTICS INC | Non-derivative | -707,526 | -$28.06M | SEC filing ↗ | SEC filing ↗ |
3 / 9 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1839435 · Period 2024-03-31
Data loaded 2026-09-23 · First reported 2024-05-15
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 834374475
}Research all 57 reported holdings.
This page includes 30 of 57 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 57 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1839435","quarter":"2024Q1","page_size":100}
get_institutional_manager_history
{"cik":"1839435","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.